Skip to Content

ETH269 8 mg (Doxazosin 8 mg)

Pill imprint ETH269 8 mg has been identified as Doxazosin mesylate 8 mg.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substance Act (CSA).

Doxazosin mesylate 8 mg ETH269 8 mg Front
Doxazosin mesylate 8 mg ETH269 8 mg Back
Doxazosin mesylate 8 mg ETH269 8 mg
Discount Card Promo
Doxazosin mesylate
Imprint:
ETH269 8 mg
Strength:
8 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Ethex Corporation
National Drug Code (NDC):
58177-0269
Inactive Ingredients:
hydrated alumina
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate
FD&C Blue No. 2 Aluminium Lake

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide